Innovation

Limited to unlimited

Innovation

Innovation is one of the core values driving our business. In the fields of medical and pharmaceuticals, where the next generation of breakthroughs is constantly on the horizon, innovation is the key to staying ahead. At CHAEUM PHARMA, we challenge the boundaries of knowledge, transforming traditional approaches into new, limited to unlimited.

Innvation

Intensive R&D

Our creativity is rooted in our unwavering commitment to preserving pure sources at the highest standards. Every material we use is meticulously selected through years of scientific research and discovery, all governed by strict disciplines.

As new technologies accelerate, CHAEUM PHARMA is enhancing its capacity for innovation, continuously creating and developing personalized, inclusive products, services, and natural experiences.

Innvation

Manufacturing

Excellence is Our Guide

At CHAEUM PHARMA, we are in a constant pursuit of excellence, striving to offer the best products and services in the industry. All of our manufacturing facilities adhere to the highest standards, ensuring the quality that has been proven and trusted over years of rigorous testing and refinement. Consistency is the cornerstone of our operations, enabling us to deliver top-tier quality to global markets.

We operate four environmentally controlled manufacturing facilities across three continents, each certified with 42 qualifications, including ISO, GMP, KGMP, FDA, CFDA, ANVISA, MDSAP, and CE (EC). These certifications are applied to each facility under stringent conditions, ensuring compliance with global quality and environmental standards.

Safety and Quality Record

In compliance with medical standards, all products are traceable under the UDI & EAN system, which allows us to conduct comprehensive market surveillance and maintain our commitment to safety and quality. Safety and quality are not just regulatory requirements for us—they are the pillars of our business, critical to our long-standing relationships with consumers, patients, and healthcare professionals.

Our quality and manufacturing processes are fully aligned with both local and international laws and regulations, reinforcing our dedication to excellence and responsibility.

Project California

Project California represents a new concept in agile manufacturing, focused on revitalizing an abandoned factory dating back to the 1980s. This initiative is part of our broader mission to foster local employment and contribute to the renovation of the city’s outskirts, particularly in the beauty sector.

Strategically targeting the U.S. market, Project California is set to be operational by the third quarter of 2027. The project is invested in and governed by CHAEUM GROUP INC., and managed by CHAEUM PHARMA.